MARCKS and inflammatory breast carcinoma: Due to the above-cited limitations of our study, further in vitro and in vivo studies are required to validate the role of MARCKS; if validated, the testing of MARCKS inhibitors in IBC pre-clinical models is warranted in this mysterious and so lethal disease.